Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Catalent Indiana, LLC
FDA Inspection
•Catalent Indiana, LLC•November 15, 2023

Catalent Indiana, LLC – FDA Inspection, Nov 15, 2023

Record Details

This FDA Inspection record concerns Catalent Indiana, LLC, with an inspection on November 15, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Catalent Indiana, LLC
Inspection Date
November 15, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Alan L. Truong
  • Andrew J. Barrowcliff
  • Charles Y. Kuo (Company Rep)
  • Jacob G. Lutz (FDA Associated Person)
  • Rafeeq A. Habeeb (FDA Associated Person)
  • Wendy G. Tan
View Company Profile

ID · d2add1e6-726c-497d-9573-a93cfc3f443d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1224264
FDA center
Biologics
Project area
Vaccines and Allergenic Products
Outcome
Form 483 issued

FDA Citations

6
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.113(b)Validation lacking for sterile drug products
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.22(d)Procedures not in writing, fully followed
  6. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Catalent Indiana, LLC

15
DateClassificationOfficeProject area
April 24, 2026Not classifiedDetroit District Office
July 14, 2025OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 12, 2023Not classifiedDetroit District Office
September 1, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 18, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 15 other inspections on the company page
Other documents for Catalent Indiana, LLC
  • FDA Inspection 1317904 - 2026-04-24
  • FDA Inspection 1264264 - 2025-07-14
  • FDA Inspection 1208718 - 2023-05-12
  • FDA Inspection 1178819 - 2022-09-01
  • FDA Inspection 1111350 - 2019-10-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Indiana, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.